Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TNGXTango Therapeutics, Inc.

Nasdaq · CIK 0001819133
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts261

Identity from submissions API

NameTango Therapeutics, Inc.
CIK0001819133
TickersTNGX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(857) 320-4900
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • BCTG Acquisition Corp. (2020-07-30T00:00:00.000Z → 2021-08-09T00:00:00.000Z)
Business address
201 BROOKLINE AVENUE
SUITE 901
BOSTON
MA
02215
MA
Mailing address
201 BROOKLINE AVENUE
SUITE 901
BOSTON
MA
02215
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

432 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468892 5505
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011255 001-39485 261566827 33 5028
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-464026 005-92241 261563368 34 17048
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000536 005-92241 261555918 34 29656
2026-11-13 4 4 0001193125-26-461212 9007
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-452635 001-39485 261533793 34 414074 1 1
2026-11-09 10-Q 10-Q 0001193125-26-452634 001-39485 261533791 34 9329637 1 1
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002952 005-92241 261529786 34 11821
2026-11-04 4 4 0001193125-26-447915 10827
2026-11-04 4 4 0001193125-26-447908 7430
2026-11-02 144 xsl144X01/primary_doc.xml 0001950047-26-010577 001-39485 261512986 33 7252
2026-10-23 8-K 8-K 7.01,8.01,9.01 0001193125-26-429423 001-39485 261479886 34 12202097 1 1
2026-10-05 4 4 0001193125-26-414500 10827
2026-09-24 4 4 0001193125-26-401327 9281
2026-09-22 144 xsl144X01/primary_doc.xml 0001950047-26-009747 001-39485 261397016 33 5759
2026-09-03 4 4 0001193125-26-381853 9015
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001916761-26-000008 005-92241 261282956 34 14695
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352271 005-92241 261281741 34 16897
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000886982-26-000510 005-92241 261279786 34 18294
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005265 005-92241 261277875 34 9356
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000425 005-92241 261276350 34 49378
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004954 005-92241 261266206 34 12876
2026-08-11 8-K 8-K 8.01,9.01 0001193125-26-344997 001-39485 261264365 34 154167 1 1
2026-08-11 424B5 424B5 0001193125-26-344989 333-291684 261264336 33 759211 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-343434 001-39485 261260614 34 405066 1 1
2026-08-11 10-Q 10-Q 0001193125-26-343424 001-39485 261260602 34 8610239 1 1
2026-08-07 8-K/A 8-K/A 5.02,7.01,9.01 0001193125-26-339070 001-39485 261251330 34 247436 1 1
2026-08-06 8-K 8-K 5.02 0001193125-26-338480 001-39485 261250567 34 143211 1 1
2026-08-05 4 4 0001193125-26-335002 10831
2026-08-03 144 xsl144X01/primary_doc.xml 0001950047-26-007562 001-39485 261233844 33 6535
2026-07-02 4 4 0001193125-26-295124 10890
2026-06-23 4 4 0001193125-26-279871 7346
2026-06-23 3 3 0001193125-26-279866 16297
2026-06-23 8-K 8-K 5.02,9.01 0001193125-26-279788 001-39485 261112202 34 178178 1 1
2026-06-17 144 xsl144X01/primary_doc.xml 0001894038-26-000002 001-39485 261099184 33 7382
2026-06-11 144 xsl144X01/primary_doc.xml 0001950047-26-005968 001-39485 261084383 33 6259
2026-06-10 8-K 8-K 1.01,9.01 0001193125-26-266078 001-39485 261080705 34 548303 1 1
2026-06-10 424B5 424B5 0001193125-26-266074 333-291684 261080694 33 836120
2026-06-10 144 xsl144X01/primary_doc.xml 0001950047-26-005901 001-39485 261080348 33 5545
2026-06-10 FWP FWP 0001193125-26-264555 333-291684 261077786 34 72585
2026-06-08 4 4 0001193125-26-262227 20712
2026-06-08 4 4 0001193125-26-262205 20543
2026-06-08 4 4 0001193125-26-262191 20701
2026-06-08 4 4 0001193125-26-262172 20641
2026-06-08 424B5 424B5 0001193125-26-261771 333-291684 261072839 33 645073
2026-06-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-260679 001-39485 261071018 34 9358136 1 1
2026-06-04 8-K 8-K 5.07 0001193125-26-257760 001-39485 261066006 34 152594 1 1
2026-06-03 4 4 0001193125-26-255940 10830
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226866 005-92241 26988173 34 15972
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001916761-26-000005 005-92241 26988137 34 15048
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003243 005-92241 26982895 34 9002
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000120 005-92241 26982610 34 12681
2026-05-13 8-K 8-K 2.02,5.02,9.01 0001193125-26-221677 001-39485 26973534 34 366486 1 1
2026-05-13 10-Q 10-Q 0001193125-26-221656 001-39485 26973472 34 7495857 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002933 005-92241 26971263 34 12616
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000221 005-92241 26961060 34 50256
2026-05-08 8-K 8-K 5.02,9.01 0001193125-26-213491 001-39485 26956341 34 206370 1 1
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001324 005-92241 26946988 34 11187
2026-05-05 4 4 0001193125-26-207096 11123
2026-05-05 4 4 0001193125-26-207094 7593
2026-05-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002005369-26-000027 005-92241 26936747 34 18661
2026-05-01 4 4 0001193125-26-201749 7838
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003936 001-39485 26933483 33 9405
2026-04-24 3 3 0001193125-26-177292 27267
2026-04-24 3 3 0001193125-26-177281 15989
2026-04-17 ARS ARS 0001193125-26-160323 001-39485 26869414 34 2695872
2026-04-17 DEFA14A DEFA14A 0001193125-26-160320 001-39485 26869411 34 300308
2026-04-17 DEF 14A DEF 14A 0001193125-26-160287 001-39485 26869385 34 4376627 1 1
2026-04-16 4 4 0001193125-26-159747 8601
2026-04-15 8-K 8-K 5.02,7.01,9.01 0001193125-26-156127 001-39485 26862730 34 321699 1 1
2026-04-02 4 4 0001193125-26-140874 9130
2026-03-27 4 4 0001193125-26-129990 9129
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002402 005-92241 26804764 34 7258
2026-03-25 144 xsl144X01/primary_doc.xml 0001950047-26-002998 001-39485 26792773 33 7249
2026-03-09 4 4 0001193125-26-098443 4730
2026-03-05 144 xsl144X01/primary_doc.xml 0001950047-26-002280 001-39485 26727035 33 6883
2026-03-05 S-8 S-8 0001193125-26-092568 333-294030 26724202 33 184226 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001193125-26-092535 001-39485 26724183 34 456366 1 1
2026-03-05 10-K 10-K 0001193125-26-092518 001-39485 26724176 34 16277685 1 1
2026-02-27 4 4 0001193125-26-083579 18556
2026-02-25 144 xsl144X01/primary_doc.xml 0001950047-26-001787 001-39485 26679438 33 5724
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-26-000119 005-92241 26644347 34 15816
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054743 005-92241 26641847 34 15094
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001066 005-92241 26640211 34 9032
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002005369-26-000012 005-92241 26630234 34 18524
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000912 005-92241 26623707 34 15671
2026-02-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-044719 005-92241 26616146 34 12688
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000056 005-92241 26607739 34 64970
2026-02-04 4 4 0001193125-26-038072 11493
2026-02-04 4 4 0001193125-26-038070 11319
2026-02-04 4 4 0001193125-26-038052 11486
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000267 005-92241 26582603 34 7056
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000726 005-92241 26545924 34 10925
2026-01-12 4 4 0001193125-26-009663 7432
2026-01-08 8-K 8-K 2.02,5.02,7.01,9.01 0001193125-26-007086 001-39485 26517702 34 5327199 1 1
2026-01-06 4 4 0001193125-26-004433 7198
2026-01-06 3 3 0001193125-26-004401 16185
2026-01-05 8-K 8-K 5.02,9.01 0001193125-26-001495 001-39485 26503882 34 174911 1 1
2025-12-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003637 333-291683 251563390 33 1855
2025-12-08 CORRESP filename1.htm 0001193125-25-311209 6572
2025-11-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-291391 005-92241 251508146 34 13752
2025-11-21 8-K 8-K 1.01,1.02 0001193125-25-290679 001-39485 251504688 34 142453 1 1
2025-11-21 S-3ASR S-3ASR 0001193125-25-290677 333-291684 251504683 33 1539950 1 1
2025-11-21 S-3 S-3 0001193125-25-290673 333-291683 251504677 33 369732 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283070 005-92241 251486820 34 14269
2025-11-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-282980 005-92241 251486376 34 12900
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004875 005-92241 251475700 34 12571
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000328 005-92241 251471040 34 42140
2025-11-04 4 4 0001193125-25-263710 5430
2025-11-04 8-K 8-K 2.02,9.01 0001193125-25-263684 001-39485 251446778 34 566000 1 1
2025-11-04 10-Q 10-Q 0001193125-25-263680 001-39485 251446773 34 8862144 1 1
2025-10-28 D xslFormDX01/primary_doc.xml 06b 0001819133-25-000003 021-562231 251421946 33 12849
2025-10-27 4 4 0001193125-25-251606 9208
2025-10-24 8-K 8-K 1.01,3.02,9.01 0001193125-25-249302 001-39485 251414224 34 722803 1 1
2025-10-24 424B5 424B5 0001193125-25-249286 333-287202 251414199 33 636183
2025-10-23 144 xsl144X01/primary_doc.xml 0001178937-25-000050 001-39485 251413786 33 8472
2025-10-23 FWP FWP 0001193125-25-247690 333-287202 251411400 34 41225
2025-10-23 8-K 8-K 2.02,8.01,9.01 0001193125-25-247658 001-39485 251411375 34 2377772 1 1
2025-09-29 4 4 0001193125-25-223227 9206
2025-09-25 144 xsl144X01/primary_doc.xml 0001178937-25-000039 001-39485 251344500 33 7788
2025-09-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002005369-25-000050 005-92241 251330948 34 25252
2025-09-17 4 4 0001193125-25-206453 9204
2025-09-17 144 xsl144X01/primary_doc.xml 0001178937-25-000037 001-39485 251319047 33 7717
2025-09-09 4 4 0001193125-25-199177 10618
2025-09-08 144 xsl144X01/primary_doc.xml 0001178937-25-000034 001-39485 251300908 33 6491
2025-09-05 144 xsl144X01/primary_doc.xml 0001178937-25-000033 001-39485 251297725 33 5883
2025-08-26 4 4 0000950170-25-111457 9196
2025-08-25 8-K 8-K 5.02 0001193125-25-187680 001-39485 251250940 34 133746 1 1
2025-08-22 144 xsl144X01/primary_doc.xml 0001178937-25-000032 001-39485 251247269 33 5225
2025-08-21 4 4 0000950170-25-110662 9191
2025-08-19 144 xsl144X01/primary_doc.xml 0001178937-25-000030 001-39485 251233486 33 4577
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003592 005-92241 251216110 34 8768
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000242 005-92241 251212649 34 42074
2025-08-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003513 005-92241 251204587 34 16036
2025-08-05 10-Q 10-Q 0000950170-25-102392 001-39485 251182773 34 8473457 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102387 001-39485 251182759 34 538063 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003135 005-92241 251132335 34 10894
2025-06-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000200 005-92241 251047768 34 52950
2025-06-09 4 4 0000950170-25-083912 7326
2025-06-09 4 4 0000950170-25-083911 7369
2025-06-09 4 4 0000950170-25-083907 7310
2025-06-09 4 4 0000950170-25-083906 7329
2025-06-09 4 4 0000950170-25-083903 7334
2025-06-06 8-K 8-K 5.03,5.07,9.01 0001193125-25-137032 001-39485 251030460 34 174153 1 1
2025-05-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001696 333-287202 25974646 33 1854
2025-05-20 UPLOAD filename1.pdf 0000000000-25-005336 333-287202 40252
2025-05-19 CORRESP filename1.htm 0001193125-25-122432 6215
2025-05-12 S-3 S-3 0001193125-25-117922 333-287202 25936152 33 1395735 1 1
2025-05-12 10-Q 10-Q 0000950170-25-068549 001-39485 25932563 34 7437445 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-068546 001-39485 25932557 34 502256 1 1
2025-04-24 DEFR14A DEFR14A 0000950170-25-057632 001-39485 25863253 34 5217426 1 1
2025-04-22 ARS ARS 0001193125-25-089325 001-39485 25858566 34 3134994
2025-04-22 DEFA14A DEFA14A 0001193125-25-089323 001-39485 25858550 34 716263
2025-04-21 DEF 14A DEF 14A 0000950170-25-056230 001-39485 25852464 34 5191492 1 1
2025-04-11 PRE 14A PRE 14A 0000950170-25-053024 001-39485 25829848 34 4260777 1 1
2025-02-27 S-8 S-8 0001193125-25-037611 333-285306 25673024 33 247643 1 1
2025-02-27 10-K 10-K 0000950170-25-028353 001-39485 25672976 34 14733485 1 1
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-028345 001-39485 25672955 34 545321 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000161 005-92241 25625753 34 15917
2025-02-06 4 4 0000950170-25-015704 7222
2025-02-06 4 4 0000950170-25-015696 7268
2025-02-06 4 4 0000950170-25-015693 7295
2025-02-06 4 4 0000950170-25-015684 7250
2025-02-05 4 4 0000950170-25-014840 7341
2025-02-05 4 4 0000950170-25-014813 7368
2025-02-05 4 4 0000950170-25-014810 7324
2025-02-05 4 4 0000950170-25-014808 7294
2025-01-13 8-K 8-K 2.02,7.01,9.01 0001193125-25-004977 001-39485 25524811 34 13773931 1 1
2025-01-02 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000895345-25-000001 005-92241 25500211 34 11796
2024-12-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-24-002974 005-92241 241531089 34 11431
2024-11-20 SC 13G SC 13G 0001193125-24-262550 005-92241 241480709 34 77545
2024-11-18 4 4 0000950170-24-128163 5800
2024-11-08 4 xslF345X05/ownership.xml 0000935836-24-000649 10274
2024-11-07 SC 13D/A ff4095518_13da-boxertango.htm 0000895345-24-000549 005-92241 241437759 34 144024
2024-11-07 4 xslF345X05/form4.xml 0000895345-24-000548 9611
2024-11-06 144 xsl144X01/primary_doc.xml 0000895345-24-000539 001-39485 241432810 33 11791
2024-11-06 10-Q 10-Q 0000950170-24-121818 001-39485 241429266 34 6810214 1 1
2024-11-06 8-K 8-K 2.02,8.01,9.01 0000950170-24-121810 001-39485 241429237 34 530322 1 1
2024-10-28 SC 13D/A ff4043262_13da5-boxertango.htm 0000895345-24-000491 005-92241 241398911 34 157089
2024-10-28 4 xslF345X05/form4.xml 0000895345-24-000485 9434
2024-10-25 144 xsl144X01/primary_doc.xml 0000895345-24-000478 001-39485 241398235 33 6524
2024-10-23 4 xslF345X05/form4.xml 0000895345-24-000470 11341
2024-10-22 144 xsl144X01/primary_doc.xml 0000895345-24-000459 001-39485 241387615 33 6648
2024-10-22 3 xslF345X02/form3.xml 0000895345-24-000457 6023
2024-10-22 144 xsl144X01/primary_doc.xml 0000895345-24-000450 001-39485 241385292 33 4958
2024-10-15 SC 13D/A ff3996442_13da4-tangoboxcap.htm 0000895345-24-000428 005-92241 241373122 34 249398
2024-10-15 SC 13D/A ff3993768_13da4-tango.htm 0000895345-24-000424 005-92241 241373035 34 146660
2024-09-17 4 4 0000950170-24-107330 9199
2024-09-13 144 xsl144X01/primary_doc.xml 0001178937-24-000057 001-39485 241298843 33 14190
2024-09-09 4 4 0000950170-24-104863 9199
2024-09-05 4 xslF345X05/form4.xml 0000895345-24-000369 5853
2024-09-05 144 xsl144X01/primary_doc.xml 0001178937-24-000050 001-39485 241282054 33 13546
2024-09-04 SC 13D/A SC 13D/A 0001193125-24-213369 005-92241 241279432 34 76200
2024-09-04 4 4 0000950170-24-103661 9200
2024-08-30 144 xsl144X01/primary_doc.xml 0001178937-24-000049 001-39485 241271181 33 13434
2024-08-29 4 4 0000950170-24-101910 9199
2024-08-27 144 xsl144X01/primary_doc.xml 0001178937-24-000048 001-39485 241249836 33 12258
2024-08-20 4 4 0000950170-24-099253 11129
2024-08-19 144 xsl144X01/primary_doc.xml 0001178937-24-000047 001-39485 241221959 33 11580
2024-08-16 144 xsl144X01/primary_doc.xml 0001178937-24-000046 001-39485 241217581 33 10971
2024-08-07 10-Q 10-Q 0000950170-24-092274 001-39485 241181412 34 6779689 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092270 001-39485 241181398 34 411079 1 1
2024-08-01 4 4 0000950170-24-089474 12538
2024-08-01 144 xsl144X01/primary_doc.xml 0001178937-24-000039 001-39485 241168084 33 10362
2024-07-31 144 xsl144X01/primary_doc.xml 0001178937-24-000038 001-39485 241163150 33 9719
2024-07-30 144 xsl144X01/primary_doc.xml 0001178937-24-000037 001-39485 241158828 33 9075
2024-07-30 4 4 0000950170-24-087862 9254
2024-07-26 144 xsl144X01/primary_doc.xml 0001178937-24-000036 001-39485 241148214 33 8431
2024-07-26 4 4 0000950170-24-086894 11130
2024-07-25 144 xsl144X01/primary_doc.xml 0001178937-24-000035 001-39485 241143061 33 8858
2024-07-24 144 xsl144X01/primary_doc.xml 0001178937-24-000034 001-39485 241139126 33 7156
2024-07-24 4 4 0000950170-24-086051 11126
2024-07-23 144 xsl144X01/primary_doc.xml 0001178937-24-000033 001-39485 241135289 33 6512
2024-07-22 144 xsl144X01/primary_doc.xml 0001178937-24-000032 001-39485 241132397 33 5866
2024-07-22 4 4 0000950170-24-085256 8683
2024-07-18 144 xsl144X01/primary_doc.xml 0001178937-24-000031 001-39485 241125593 33 5222
2024-07-18 4 4 0000950170-24-084580 9198
2024-07-17 144 xsl144X01/primary_doc.xml 0001178937-24-000030 001-39485 241123100 33 5091
2024-07-02 4 xslF345X05/form4.xml 0000895345-24-000245 11202
2024-06-07 4 xslF345X05/form4.xml 0000895345-24-000225 9661
2024-06-07 4 4 0000950170-24-070906 7306
2024-06-07 4 4 0000950170-24-070884 7290
2024-06-07 4 4 0000950170-24-070875 9329
2024-06-07 4 4 0000950170-24-070860 7309
2024-06-07 4 4 0000950170-24-070851 7314
2024-06-06 8-K 8-K 5.03,5.07,9.01 0001193125-24-156048 001-39485 241025040 34 182048 1 1
2024-06-05 144 xsl144X01/primary_doc.xml 0001950047-24-004451 001-39485 241022338 33 4917
2024-05-23 8-K 8-K 7.01,8.01,9.01 0001193125-24-145434 001-39485 24975194 34 175601 1 1
2024-05-08 10-Q 10-Q 0000950170-24-055065 001-39485 24924241 34 6092770 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055062 001-39485 24924233 34 379128 1 1
2024-05-03 4 xslF345X05/form4.xml 0000895345-24-000151 12474
2024-05-03 144 xsl144X01/primary_doc.xml 0000895345-24-000150 001-39485 24915323 33 5353
2024-05-02 144 xsl144X01/primary_doc.xml 0000895345-24-000149 001-39485 24910558 33 5352
2024-05-01 144 xsl144X01/primary_doc.xml 0000895345-24-000148 001-39485 24904873 33 5343
2024-04-29 ARS ARS 0001193125-24-122399 001-39485 24891300 34 13402577
2024-04-29 DEF 14A DEF 14A 0000950170-24-049881 001-39485 24891066 34 1309628
2024-04-17 PRE 14A PRE 14A 0000950170-24-045159 001-39485 24851766 34 1309909
2024-04-08 SC 13G/A SC 13G/A 0001193125-24-089187 005-92241 24828253 34 104678
2024-03-18 S-8 S-8 0001193125-24-069689 333-278016 24756992 33 68752
2024-03-18 10-K 10-K 0000950170-24-032516 001-39485 24756910 34 13540635 1 1
2024-03-18 8-K 8-K 2.02,9.01 0000950170-24-032513 001-39485 24756900 34 431059 1 1
2024-02-21 4 4 0000950170-24-018198 8679
2024-02-21 144 xsl144X01/primary_doc.xml 0001178937-24-000009 001-39485 24657769 33 6752
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036184 005-92241 24638053 34 103907
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-033887 005-92241 24626997 34 45216
2024-02-09 SC 13G/A filing.txt 0000315066-24-001497 005-92241 24612020 34 8290
2024-02-08 4 4 0000950170-24-012999 7256
2024-02-08 4 4 0000950170-24-012997 7228
2024-02-08 4 4 0000950170-24-012996 7273
2024-02-08 4 4 0000950170-24-012991 7300
2024-02-07 8-K 8-K 2.02 0001193125-24-025907 001-39485 24602087 34 150435 1 1
2024-02-05 4 4 0000950170-24-011263 7343
2024-02-05 4 4 0000950170-24-011257 7428
2024-02-05 4 4 0000950170-24-011253 7324
2024-02-05 4 4 0000950170-24-011248 7300
2023-11-14 3 3 0000950170-23-063836 12003
2023-11-08 10-Q 10-Q 0000950170-23-060682 001-39485 231385956 34 7614948 1 1
2023-11-08 8-K 8-K 2.02,9.01 0000950170-23-060671 001-39485 231385934 34 494392 1 1
2023-11-02 4 4 0000950170-23-058314 4803
2023-10-18 SC 13D/A ff2609617_13da3-tango.htm 0000895345-23-000591 005-92241 231332912 34 266111
2023-10-17 4/A xslF345X05/form4.xml 0000895345-23-000589 18304
2023-10-17 4 xslF345X05/form4.xml 0000895345-23-000588 18140
2023-10-16 3 xslF345X02/ownership.xml 0000935836-23-000663 5224
2023-10-16 SC 13G/A tango13g.htm 0000935836-23-000662 005-92241 231327279 34 47196
2023-10-11 4 xslF345X05/form4.xml 0000895345-23-000574 17060
2023-10-11 4/A xslF345X05/form4.xml 0000895345-23-000573 18204
2023-10-10 144 xsl144X01/primary_doc.xml 0000895345-23-000560 001-39485 231319320 33 4192
2023-10-10 144 xsl144X01/primary_doc.xml 0000895345-23-000559 001-39485 231319318 33 4654
2023-09-21 SC 13G tngx13g.htm 0000935836-23-000618 005-92241 231269782 34 47410
2023-09-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-11 16:01:00 9999999995-23-002627 333-274298 231248933 33 1813
2023-09-11 SC 13G/A filing.txt 0000315066-23-002572 005-92241 231246748 34 8219
2023-09-07 CORRESP filename1.htm 0001193125-23-230626 5702
2023-09-07 UPLOAD filename1.pdf 0000000000-23-009912 40382
2023-09-01 S-3 FORM S-3 0001193125-23-226862 333-274298 231230613 33 298081
2023-08-31 4 4 0000950170-23-045783 7229
2023-08-31 3 3 0000950170-23-045782 12658
2023-08-30 8-K 8-K 5.02 0001193125-23-224253 001-39485 231223637 34 151414 1 1
2023-08-24 D xslFormDX01/primary_doc.xml 06b 0001802806-23-000009 021-490627 231202272 33 14530
2023-08-22 3 FORM 3 SUBMISSION 0000899243-23-018343 8527
2023-08-21 SC 13G SC 13G 0001104659-23-093931 005-92241 231189304 34 118984
2023-08-16 SC 13D/A ff2392812_13da2-tango.htm 0000895345-23-000503 005-92241 231178699 34 272051
2023-08-15 4 xslF345X05/form4.xml 0000895345-23-000498 17378
2023-08-10 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-23-208100 001-39485 231157176 34 501954 1 1
2023-08-07 10-Q 10-Q 0000950170-23-038750 001-39485 231145641 34 8110221 1 1
2023-08-07 8-K 8-K 2.02,5.02,9.01 0000950170-23-038742 001-39485 231145586 34 539066 1 1
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015020 7592
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015019 7651
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015016 7616
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015015 7637
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015014 7608
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015012 10973
2023-06-07 8-K 8-K 5.07 0001193125-23-162609 001-39485 23999585 34 157535 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019140 001-39485 23899989 34 7174598 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019133 001-39485 23899968 34 471084 1 1
2023-04-24 ARS ARS 0001193125-23-112979 001-39485 23840661 34 5189281
2023-04-24 DEFA14A DEFA14A 0001193125-23-112957 001-39485 23840597 34 714410
2023-04-24 DEF 14A DEF 14A 0000950170-23-014108 001-39485 23840486 34 2027674
2023-03-27 10-K 10-K 0000950170-23-009854 001-39485 23761449 34 15716126 1 1
2023-03-27 8-K 8-K 2.02,9.01 0000950170-23-009852 001-39485 23761436 34 532339 1 1
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006736 7608
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006735 7588
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006733 7604
2023-03-02 3 FORM 3 SUBMISSION 0000899243-23-006734 7597
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006732 7561
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006728 7583
2023-02-28 8-K 8-K 5.02,7.01,9.01 0001193125-23-052289 001-39485 23678463 34 188868 1 1
2023-02-14 SC 13G/A schedule13ga.htm 0000929638-23-000552 005-92241 23627663 34 116439
2023-02-14 SC 13G/A d9938373_13g-a.htm 0000919574-23-001339 005-92241 23621586 34 141965
2023-02-09 SC 13G/A filing.txt 0000315066-23-002128 005-92241 23605117 34 8196
2023-02-07 S-8 S-8 0001193125-23-026914 333-269620 23595098 33 212259
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037607 5530
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037603 7450
2022-11-10 10-Q 10-Q 0000950170-22-024219 001-39485 221375282 34 9802759 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024215 001-39485 221375253 34 582884 1 1
2022-10-13 4 FORM 4 SUBMISSION 0000899243-22-033595 15560
2022-10-06 4 FORM 4 SUBMISSION 0000899243-22-033177 13168
2022-09-28 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-248070,2022-09-28 9999999995-22-002840 333-259448 221277619 33 1818
2022-09-21 POS AM POS AM 0001193125-22-248070 333-259448 221255040 33 390527
2022-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-12 16:01:00 9999999995-22-002669 333-267224 221239655 33 1805
2022-09-08 CORRESP filename1.htm 0001193125-22-240987 6491
2022-09-07 UPLOAD filename1.pdf 0000000000-22-009726 40171
2022-09-01 S-3 S-3 0001193125-22-236521 333-267224 221221098 33 1363368
2022-08-10 424B3 424B3 0000950170-22-016514 333-259448 221152562 33 2897904
2022-08-10 10-Q 10-Q 0000950170-22-016257 001-39485 221150394 34 8874054 1 1
2022-08-10 8-K 8-K 2.02,9.01 0000950170-22-016251 001-39485 221150376 34 543095 1 1
2022-07-11 SC 13G SC 13G 0001193125-22-191245 005-92241 221076950 34 115835
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024404 5525
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024402 5487
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024401 5517
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024399 5560
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024398 5501
2022-06-28 4 FORM 4 SUBMISSION 0000899243-22-024396 5546
2022-06-10 424B3 424B3 0000950170-22-011484 333-259448 221009083 33 85107
2022-06-10 8-K 8-K 5.07 0000950170-22-011475 001-39485 221008889 34 184265 1 1
2022-05-11 424B3 424B3 0000950170-22-009313 333-259448 22913721 33 2389411
2022-05-11 10-Q 10-Q 0000950170-22-009139 001-39485 22912070 34 8640786 1 1
2022-05-11 8-K 8-K 2.02,9.01 0000950170-22-009137 001-39485 22912049 34 438190 1 1
2022-04-26 DEFA14A DEFA14A 0000950170-22-006138 001-39485 22851847 34 236258
2022-04-26 DEF 14A DEF 14A 0000950170-22-006137 001-39485 22851830 34 1351387
2022-03-31 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-086874,2022-03-31 9999999995-22-000785 333-259448 22795644 33 1817
2022-03-28 POS AM POS AM 0001193125-22-086874 333-259448 22776547 33 14273255 1 1
2022-03-28 S-8 S-8 0001193125-22-086625 333-263893 22775523 33 61110
2022-03-28 10-K 10-K 0000950170-22-004721 001-39485 22773212 34 18052941 1 1
2022-03-28 8-K 8-K 2.02,9.01 0001193125-22-085927 001-39485 22773181 34 230435 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022772 005-92241 22631924 34 87450
2022-02-14 SC 13G schedule13g.htm 0000929638-22-000493 005-92241 22630340 34 63580
2022-02-10 SC 13G/A SC 13G/A 0001193125-22-034520 005-92241 22614450 34 101314
2022-02-09 SC 13G filing.txt 0000315066-22-001220 005-92241 22604653 34 8462
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004605 5490
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004606 9867
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004604 9877
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004603 9861
2022-01-04 SC 13D/A SC 13D/A 0001193125-22-001819 005-92241 22507162 34 162018
2022-01-04 3 FORM 3 SUBMISSION 0000899243-22-000535 5988
2021-12-10 4 FORM 4 - 0001179110-21-010826 001-37359 211485656 34 7232
2021-12-10 3 FORM 3 - 0001179110-21-010825 001-37359 211485649 34 7168
2021-11-09 424B3 424B3 0000950170-21-003795 333-259448 211393146 33 3377110
2021-11-09 10-Q 10-Q 0000950170-21-003734 001-39485 211392130 34 10995437 1 1
2021-11-09 8-K 8-K 2.02,9.01 0001193125-21-323744 001-39485 211389847 34 224693 1 1
2021-11-03 4 FORM 4 SUBMISSION 0000899243-21-042702 5521
2021-11-01 3 FORM 3 SUBMISSION 0000899243-21-042163 7373
2021-11-01 3 FORM 3 SUBMISSION 0000899243-21-042162 8633
2021-10-14 S-8 S-8 0001193125-21-298942 333-260258 211324128 33 408461
2021-10-08 424B3 424B3 0001193125-21-294419 333-259448 211313603 33 5476886
2021-09-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-29 16:01:00 9999999995-21-003701 333-259448 211293448 33 1805
2021-09-29 424B3 424B3 0001193125-21-286877 333-259448 211292648 33 5475868
2021-09-27 CORRESP filename1.htm 0001193125-21-284149 7149
2021-09-17 UPLOAD filename1.pdf 0000000000-21-011341 40324
2021-09-10 S-1 S-1 0001193125-21-269987 333-259448 211247242 33 17877172 1 1
2021-09-10 SC 13G SC 13G 0001104659-21-114528 005-92241 211246441 34 46542
2021-08-20 SC 13D SC 13D 0001193125-21-252792 005-92241 211194234 34 150528
2021-08-20 3 FORM 3 SUBMISSION 0000899243-21-033829 4473
2021-08-20 3 FORM 3 SUBMISSION 0000899243-21-033821 10266
2021-08-19 SC 13G d8926024_sc13-g.htm 0000919574-21-005486 005-92241 211190897 34 141784
2021-08-19 SC 13D SC 13D 0001193125-21-251568 005-92241 211190497 34 83911
2021-08-16 4 FORM 4 SUBMISSION 0000899243-21-033151 5531
2021-08-16 4 FORM 4 SUBMISSION 0000899243-21-033150 5553
2021-08-16 4 FORM 4 SUBMISSION 0000899243-21-033152 5535
2021-08-13 8-K 8-K 2.01,3.03,4.01,5.01,5.02,5.03,5.05,5.06,5.07 0001193125-21-246234 001-39485 211173376 34 2355873 1 1
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032900 12844
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032899 11584
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032896 7405
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032895 8535
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032894 8518
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032891 8535
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032890 8575
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032889 15359
2021-08-12 3 FORM 3 SUBMISSION 0000899243-21-032841 8524
2021-08-09 10-Q QUARTERLY REPORT 0001213900-21-040828 001-39485 211154150 34 2597873 1 1
2021-07-19 424B3 PROXY STATEMENT 0001213900-21-037332 333-255354 211096661 33 23750223
2021-07-16 SEC STAFF LETTER filename1.pdf 9999999997-21-004172 271717
2021-07-16 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2021-07-16 16:00:00 9999999995-21-002806 333-255354 211096736 33 1692
2021-07-16 S-4/A AMENDMENT NO. 3 TO FORM S-4 0001213900-21-037131 333-255354 211093878 33 2749707 1
2021-07-15 CORRESP filename1.htm 0001213900-21-037132 7702
2021-07-06 S-4/A AMENDMENT NO. 2 TO FORM S-4 0001213900-21-035641 333-255354 211072306 33 26765303 1
2021-07-02 CORRESP filename1.htm 0001213900-21-035643 28711
2021-06-30 UPLOAD filename1.pdf 0000000000-21-008090 46543
2021-06-23 SEC STAFF LETTER filename1.pdf 9999999997-21-003567 272323
2021-06-17 CORRESP filename1.htm 0001213900-21-032847 58935
2021-06-17 S-4/A REGISTRATION STATEMENT 0001213900-21-032845 333-255354 211023399 33 26153942 1

Latest XBRL company facts

One latest value per concept from companyfacts (261 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 169.46M 2026-11-02 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
dei EntityPublicFloat Entity Public Float USD 528.40M 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-092518
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.63M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160287
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160287
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 10.11M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160287
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.82M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160287
ffd NetFeeAmt NetFeeAmt USD 50,322.2 2026-08-11 424B5 2026-08-11 0001193125-26-344989
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 400.00M 2026-08-11 424B5 2026-08-11 0001193125-26-344989
ffd TtlFeeAmt TtlFeeAmt USD 55,240 2026-08-11 424B5 2026-08-11 0001193125-26-344989
ffd TtlOfferingAmt TtlOfferingAmt USD 400.00M 2026-08-11 424B5 2026-08-11 0001193125-26-344989
ffd TtlOffsetAmt TtlOffsetAmt USD 4,917.8 2026-08-11 424B5 2026-08-11 0001193125-26-344989
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-11 424B5 2026-08-11 0001193125-26-344989
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2.00M 2022-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032516
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 526 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 292,811 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 11.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -4.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.76B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 6.13M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 6,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 24.91M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD -9.62M 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 52.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AmortizationOfDeferredSalesCommissions Amortization of Deferred Sales Commissions USD 5.80M 2020-09-08 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap Assets Assets USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AssetsCurrent Assets, Current USD 992.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 166.76M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036927
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 166.82M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 895.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 890.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 1.50M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage pure 1 2021-03-31 2021 Q1 10-Q 2021-05-14 0001213900-21-026397
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 140,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap Cash Cash USD 600,000 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 86.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -731,147 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 977.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 88.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 88.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -25.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 21.38M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CommonStockSharesHeldInEmployeeTrust Common Stock, Shares Held in Employee Trust USD 4,000 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 169.21M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 169.21M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap CommonStockValue Common Stock, Value, Issued USD 169,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -173.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 53.80M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 166.53M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 6,864 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 10 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap DebtInstrumentUnusedBorrowingCapacityFee Debt Instrument, Unused Borrowing Capacity, Fee USD 127,000 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 63,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-121818
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 6.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 890.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 890.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -31,262 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 6,864 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 11.32M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 9.60M 2020-09-08 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 17.03M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 197.92M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 63.30M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 11.32M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 78.50M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 4.56M 2023-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032516
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 35.93M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other USD 7.32M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 31,262 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 2.28M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 186.60M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 9.85M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap Depreciation Depreciation USD 1.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.29 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.226 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.002 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 8.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap FranchisorCosts Franchisor Costs USD 3,029 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 67.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -169.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 22.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -21.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -390,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 6.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 440 2020-05-21 2020-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 866,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -2.00M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 244,163 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD -6,338 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -62.38M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -32,141 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap InterestAndDividendIncomeSecuritiesOther Interest and Dividend Income, Securities, Operating, Other USD 32,300 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 13.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap InterestIncomeOther Interest Income, Other USD 32,300 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 32,300 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap LeaseCost Lease, Cost USD 9.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 44.37M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 20.67M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028353
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.31M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.31M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028353
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.31M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 6.13M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.95M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 10.80M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 2.60M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap Liabilities Liabilities USD 53.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap LiabilitiesCurrent Liabilities, Current USD 25.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 890.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 754.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -660.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -120.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -169.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -36.19M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0000950170-21-003734
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -1.00M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD -1.00M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap NetInvestmentIncome Net Investment Income USD 36,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 17.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingExpenses Operating Expenses USD 186.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -186.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingLeaseCost Operating Lease, Cost USD 6.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 33.57M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 28.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 32.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 246,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -3.88M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 13,500 2020-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 5,000 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 4.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032516
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 40,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 874.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 0.34 2022-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 15.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 151,355 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 689,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 10.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 166.75M 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 41.72M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-121818
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 29.99M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.33M 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 73,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019140
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 166.80M 2020-09-01 2020-09-08 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 25 2020-05-21 2020-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -127,232 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 214.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ProceedsFromSaleOfOtherInvestments Proceeds from Sale of Other Investments USD 32,513 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 41.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -169.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 17.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 60,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 4.70M 2017-03-01 2017-03-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 119.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RestrictedCash Restricted Cash USD 2.60M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 2.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RestrictedInvestmentsPercentOfNetAssets Restricted Investments, Percent of Net Assets pure 0.2 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -772.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 48.35M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 30,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001213900-21-026397
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 13.20M 2023-08-11 2024 Q3 10-Q 2024-11-06 0000950170-24-121818
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 49.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 52.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.75 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.72 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.67 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.014 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.004 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004721
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 201.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 11.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.86 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 9.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 8.83M 2021-09-30 2021 Q3 10-Q 2021-11-09 0000950170-21-003734
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 336.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 22.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.82 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 9.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap SharePrice Share Price USD/shares 0.35 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036927
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 133,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 980.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 25 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 6.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 3.04M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 62.78M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 166.75M 2020-05-21 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.06M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0000950170-23-009854
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -764,601 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001213900-21-040828
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 689,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap SubleaseIncome Sublease Income USD 117,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 35,000 2022-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032516
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap TemporaryEquityShareSubscriptions Temporary Equity, Share Subscriptions shares 15.74M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019249
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD -41,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 30.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092518
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 157.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 87.67M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009139
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 157.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-452634

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →